文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

脓毒症诱导的弥散性血管内凝血抗凝治疗预后指标的确定

Determining prognostic indicator for anticoagulant therapy in sepsis-induced disseminated intravascular coagulation.
PubMed 文献 · J Intensive Care · 2024-06-24
一句话结论在抗凝血酶治疗3天后,由DIC缓解和SOFA评分变化率构成的复合预后指数(CPI)>0.19可判断脓毒症DIC患者28天存活,推导队列AUROC 0.76、验证队列0.71。

本研究旨在开发并验证一个预后指数,用于识别接受抗凝血酶浓缩物治疗3天后的脓毒症相关DIC患者的28天死亡风险。推导队列来自上市后调查数据集,验证队列来自日本全国脓毒症登记数据。多变量分析确定DIC缓解(HR 0.31,95%CI 0.22-0.45,P<0.0001)和SOFA评分变化率(HR 0.42,95%CI 0.36-0.50,P<0.0001)为死亡的独立预测因素。构建的复合预后指数(CPI)为DIC缓解(是1,否0)加SOFA评分变化率,CPI高于0.19判断为存活,推导队列AUROC 0.76,验证队列AUROC 0.71。

要点

  • 推导队列1492例中252例(16.9%)在28天内死亡。
  • 多变量分析显示DIC缓解(HR 0.31,95%CI 0.22-0.45,P<0.0001)和SOFA评分变化率(HR 0.42,95%CI 0.36-0.50,P<0.0001)是死亡的独立预测因素。
  • CPI计算公式:DIC缓解(是1,否0)+(第0天SOFA评分-第3天SOFA评分)/第0天SOFA评分。
  • CPI高于0.19时判断患者存活;推导队列AUROC 0.76,验证队列AUROC 0.71。
  • CPI简单易算,作者认为对接受抗凝血酶治疗的脓毒症DIC患者28天生存预测有用。

适用人群与场景

  • 接受抗凝血酶浓缩物治疗3天后的脓毒症相关DIC患者。

诊断标准与关键阈值

  • CPI>0.19判断为存活。
  • CPI=DIC缓解(是1,否0)+SOFA评分变化率(第0天SOFA评分-第3天SOFA评分/第0天SOFA评分)。

研究设计与关键结果

  • 推导队列来自上市后调查数据集,验证队列来自日本全国脓毒症登记数据。
  • 推导队列1492例中252例(16.9%)在28天内死亡。
  • 多变量分析:DIC缓解(HR 0.31,95%CI 0.22-0.45,P<0.0001)和SOFA评分变化率(HR 0.42,95%CI 0.36-0.50,P<0.0001)是死亡的独立预测因素。
  • 推导队列AUROC为0.76,验证队列AUROC为0.71。

证据类型、等级与局限

  • 证据类型:队列研究(推导队列来自上市后调查数据集,验证队列来自日本全国脓毒症登记数据)。
  • 局限:原文未报告局限性

对床旁实践的改变

  • 对接受抗凝血酶浓缩物治疗3天后的脓毒症DIC患者,可计算CPI,CPI>0.19判断为存活。
  • 作者认为CPI简单易算,对预测28天生存有用。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: There is no reliable indicator that can assess the treatment effect of anticoagulant therapy for sepsis-associated disseminated intravascular coagulation (DIC) in the short term. The aim of this study is to develop and validate a prognostic index identifying 28-day mortality in septic DIC patients treated with antithrombin concentrate after a 3-day treatment.

METHODS: The cohort for derivation was established utilizing the dataset from post-marketing surveys, while the cohort for validation was acquired from Japan's nationwide sepsis registry data. Through univariate and multivariate analyses, variables that were independently associated with 28-day mortality were identified within the derivation cohort. Risk variables were then assigned a weighted score based on the risk prediction function, leading to the development of a composite index. Subsequently, the area under the receiver operating characteristic curve (AUROC). 28-day survival was compared by Kaplan-Meier analysis.

RESULTS: In the derivation cohort, 252 (16.9%) of the 1492 patients deceased within 28 days. Multivariable analysis identified DIC resolution (hazard ratio [HR]: 0.31, 95% confidence interval [CI]: 0.22-0.45, P < 0.0001) and rate of Sequential Organ Failure Assessment (SOFA) score change (HR: 0.42, 95% CI: 0.36-0.50, P < 0.0001) were identified as independent predictors of death. The composite prognostic index (CPI) was constructed as DIC resolution (yes: 1, no: 0) + rate of SOFA score change (Day 0 SOFA score-Day 3 SOFA score/Day 0 SOFA score). When the CPI is higher than 0.19, the patients are judged to survive. Concerning the derivation cohort, AUROC for survival was 0.76. As for the validation cohort, AUROC was 0.71.

CONCLUSION: CPI can predict the 28-day survival of septic patients with DIC who have undergone antithrombin treatment. It is simple and easy to calculate and will be useful in practice.

来源:J Intensive Care,查看原文。版权归原作者所有。

参考来源

  1. Iba T, Yamakawa K, Shiko Y, et al. Determining prognostic indicator for anticoagulant therapy in sepsis-induced disseminated intravascular coagulation. J Intensive Care. 2024. PMID: 38915122. doi:10.1186/s40560-024-00739-x

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。